IPC-klasse
Fullmektig i Norge:
Fullmektig i EP:
2008.05.16, US 127889 P
2008.08.28, US 190545 P
2008.12.08, US 201240 P
2009.03.27, US 164333 P
BANI DANIELE ET AL: "Relaxin counteracts asthma-like reaction induced by inhaled antigen in sensitized guinea pigs" ENDOCRINOLOGY, vol. 138, no. 5, 1997, pages 1909-1915, XP002579921 ISSN: 0013-7227 (B1)
anonymous: "Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure"[Online] 10 November 2008 (2008-11-10), pages 1-2, XP002579926 Corthera Inc. News Retrieved from the Internet: URL:http://www.corthera.com/investor200811 10.html> [retrieved on 2010-04-27] (B1)
BAS Medical: "NCT00520806 on 2008_04_23: ClinicalTrials.gov Archive"[Online] 23 April 2008 (2008-04-23), pages 1-2, XP002579920 Retrieved from the Internet: URL:http://clinicaltrials.gov/archive/NCT0 0520806/2008_04_23> [retrieved on 2010-04-23] (B1)
DSCHIETZIG T ET AL: "404 A pilot safety and dose-finding trial of intravenous recombinant human relaxin (rhRlx) in compensated congestive heart failure" EUROPEAN JOURNAL OF HEART FAILURE SUPPLEMENTS, ELSEVIER LNKD- DOI:10.1016/S1567-4215(07)60252-5, vol. 6, no. 1, 1 June 2007 (2007-06-01), page 90, XP022778440 ISSN: 1567-4215 [retrieved on 2007-06-01] (B1)
JEYABALAN ARUNDHATHI ET AL: "Renal function during normal pregnancy and preeclampsia" FRONTIERS IN BIOSCIENCE, vol. 12, January 2007 (2007-01), pages 2425-2437, XP009132774 ISSN: 1093-9946 (B1)
NISTRI SILVIA ET AL: "Relaxin as a cardiovascular hormone: Physiology, pathophysiology and therapeutic promises" CARDIOVASCULAR & HEMATOLOGICAL AGENTS IN MEDICINAL CHEMISTRY, vol. 5, no. 2, April 2007 (2007-04), pages 101-108, XP009132812 ISSN: 1871-5257 (B1)
SAM L TEICHMAN ET AL: "Relaxin, a pleiotropic vasodilator for the treatment of heart failure" HEART FAILURE REVIEWS, KLUWER ACADEMIC PUBLISHERS, BO, vol. 14, no. 4, 20 December 2008 (2008-12-20), pages 321-329, XP019748833 ISSN: 1573-7322 (B1)
SHERWOOD O DAVID: "Relaxin's physiological roles and other diverse actions" ENDOCRINE REVIEWS, vol. 25, no. 2, 1 April 2004 (2004-04-01), pages 205-234, XP002579925 ISSN: 0163-769X (B1)
SHIN DAVID D ET AL: "Review of current and investigational pharmacologic agents for acute heart failure syndromes" AMERICAN JOURNAL OF CARDIOLOGY, vol. 99, no. 2A, Suppl. S, January 2007 (2007-01), pages 4A-23A, XP002579923 ISSN: 0002-9149 (B1)
TEERLINK J R ET AL: "Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study" LANCET THE, LANCET LIMITED. LONDON, GB LNKD- DOI:10.1016/S0140-6736(09)60622-X, vol. 373, no. 9673, 25 April 2009 (2009-04-25), pages 1429-1439, XP026023566 ISSN: 0140-6736 [retrieved on 2009-04-23] (B1)
TEERLINK JOHN R ET AL: "Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.", LANCET 5 JAN 2013, vol. 381, no. 9860, 5 January 2013 (2013-01-05), pages 29-39, ISSN: 1474-547X (B1)
US-A- 5 166 191 (B1)
US-A1- 2007 202 080 (B1)
WO-A2-02/40500 (B1)
anonymous: "Breathing difficulty: MedlinePlus Medical Encyclopedia"[Online] 27 February 2008 (2008-02-27), pages 1-3, XP002579927 Retrieved from the Internet: URL:http://web.archive.org/web/20080227003 514/http://www.nlm.nih.gov/medlineplus/enc y/article/003075.htm> [retrieved on 2010-04-23] (B1)
BANI DANIELE: "Relaxin: A pleiotropic hormone" GENERAL PHARMACOLOGY, vol. 28, no. 1, 1997, pages 13-22, XP002579922 ISSN: 0306-3623 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
Patent opphørt | Ikke betalt årsavgift |
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Utgående
EP Opphørt for ikke betalt årsavgift (3206)
|
Utgående
EP Batch Påminnelse om ikke betalt årsavgift (3331)
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Batch Varsel om betaling av første årsavgift (3319)
|
Utgående
EP Registreringsbrev (3210)
|
Innkommende
E-post
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 9. avg. år (EP) | 2017.05.10 | 2850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2016.05.13 | 2550 | CPA GLOBAL LTD | Betalt og godkjent |
31513403 expand_more expand_less | 2015.10.15 | 5500 | Orsnes Patent ApS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|